ACR Annual Meeting Call for Abstracts

ACR members and nonmembers are invited to submit abstracts for ACR 2026™, the Annual Meeting of the American College of Radiology (ACR), May 2-6 at the Washington Hilton in Washington, DC.

Accepted abstracts will be displayed via ePoster format during the meeting, giving authors an opportunity to have their abstracts seen by experts in the field throughout the duration of the Annual Meeting. There are no live abstract presentations.

Key Dates

Submission Deadline: January 26, 2026
Disposition Notifications: Early March 2026

Send questions about the online submission process to annualmeeting@acr.org. Many answers to questions can be found on this page. The information listed on this page is subject to change due to circumstances beyond ACR’s control.

General Information

Abstract Submission Dates: The online abstract submission site will open early November 2025 and will close at 11:59 p.m. ET on January 26, 2026.

Qualifications: The abstract submission site is open to ACR members and nonmembers. All trainees, young physicians, radiologists, medical physicists, radiation oncologists and representatives from other professions related to the subject categories listed below.

Modifications: Submitters may return to the online system to edit abstracts, add co-authors, revise information, correct typographical errors, tables, graphics, or delete a submission at any time before the submission deadline.

Notifications: Disposition notifications will be sent to the first author via email in early March 2026.

Withdrawals: The deadline to withdraw an accepted abstract will be late March 2026 and the exact date will be noted in the disposition notification. Withdrawals must be made by written request to annualmeeting@acr.org. Withdrawal of an accepted abstract after this date or failure to submit an ePoster by the deadline may result in the first author and all co-authors’ disqualification from abstract submission for the following ACR Annual Meeting.

Loading component...

Additional Information

ADVOCACY, ECONOMICS AND HEALTH POLICY
Advocacy abstracts should pertain to federal and state issues that relate to imaging issues. These abstracts are not intended to target patient-related advocacy efforts regarding patient rights protection.

Economics and Health Policy abstracts focus on areas for radiology and radiation oncology services related to coverage of services, reporting/coding and reimbursement for new, revised and existing services, policy and payment issues related to third party payers, tracking Medicaid managed care organizations, and new payment models.

INFORMATICS AND DATA SCIENCE
Should pertain to one or more of the following areas:

Artificial Intelligence (AI)
Electronic medical records (EMRs)
PACS
Interoperability
CAD
Speech-recognition software
Enterprise imaging
Radiology business analytics
Social media

LEADERSHIP AND PRACTICE MANAGEMENT
May target any of the following areas:

Strategic initiatives that leaders can use to transition to value-based care
Operational metrics and processes for optimizing organizational effectiveness
Economic drivers catalyzing changes in healthcare practice
Negotiation principles and applications
Leadership development
Developing a culture of quality and safety
Medicolegal/ethical dilemmas

QUALITY AND SAFETY
Should pertain to one or more of the following areas:

Patient safety (including radiation dose optimization)
MRI safety
Contrast media use
Diagnostic or breast imaging accreditation and centers of excellence programs
Implementation of evidence-based radiology guidelines, practice parameters, technical standards, Appropriateness Criteria, or Appropriate Use Criteria
Quality management in radiology practice (including quality improvement tools and methods such as use of data registries and structured reporting)
Building a quality infrastructure

TRAINING AND EDUCATION
Training and Education abstracts should introduce aspects of education theory that improve the way we educate trainees and colleagues. Abstracts focused on clinical radiology (i.e., more traditional abstracts seen at other national radiology meetings) will not be considered for this meeting.

The first author must:

Obtain approval in advance from all co-authors before placing their names on the abstract. Submission of an abstract denotes that co-authors as well as authors have read the abstract, take responsibility for its content, and approve that their names appear on the abstract. Failure to obtain approval from all authors will result in immediate rejection of the abstract.
A maximum of ten (10) authors may be listed on each abstract. Authorship credit should only be given if all three of the following criteria are met. Each author must have made substantial contributions to:

Conception and design, or analysis and interpretation of data
Drafting the abstract or revising it critically for important intellectual content
Final approval of the version to be submitted/published.

Include the affiliation for every author. Spell out the institutions in their entirety and capitalize the first letter of each proper name. Examples: Johns Hopkins University, University of Texas Southwestern Medical Center
Include a concise statement of the research under the ‘purpose’ tab and the overall objectives for the abstract. Define all concepts and abbreviations at first use.
Describe experimental methods briefly (including relevant numbers of patients).
Ensure that patient confidentiality is protected according to HIPAA regulations.
Describe specific findings and analysis of data. Promises such as “to be completed” will not be considered.
Include specific conclusions, with supporting statistical analyses when appropriate. Concluding statements such as “the results will be discussed” will not be considered.
Refrain from submitting multiple abstracts on overlapping facets of the same project unless each abstract has important, novel information and clearly stands on its own. Repetitive abstracts will be rejected.
Remove brand names from the abstract title or body. Use generic terms if referencing a medical device and/or pharmaceutical product.
Abstracts that have been presented at other meetings may be submitted for the ACR Annual meeting if it adheres to current ACR Abstract and ePoster guidelines.
Resolve any issues relating to patent matters before submitting the abstract.
Agree to the ACR embargo and copyright policies.
Disclose any financial interest in accordance with ACR’s disclosure of financial relationships policy. List any financial interests, assistance, or relationships with companies, supporters or commercial products that are related to the research (for example, research support, grants, sponsors, stockholder, etc.). Each co-author must complete his/her own financial disclosure and attestation form. Note: ACR will not provide continuing medical education credit for ePosters; however, financial disclosures are still required.
Ensure that the first author of an abstract does NOT have a financial interest in the scientific content of the abstract. If the first author has a conflict of interest related to the content, choose a co-author who does not have a relationship to the commercial interests related to the content to be the first author.
Inform all co-authors of the status of the submitted abstract. The first author will receive all notifications and communications related to the accepted abstract(s) and is responsible for informing all co-authors of acceptance at the meeting.

In accordance with HIPAA regulations, patient confidentiality must be protected. Names, dates of scans, birth dates, ages, medical record numbers, zip codes and identities must not be included in the abstract or on images and graphs.
The maximum character limit of the abstract is 2,200 including spaces. Use simple fonts.
Italics, underline, bold, superscript, and subscript formatting, Greek characters (both upper and lowercase), scientific characters, charts, tables, and graphs are accepted in the body of the abstract only. Do not use these in the title of the abstract.
The abstract may contain one small image and one graph. A minimum resolution of 500 dpi and format of png or pdf is required.
You may type or copy and paste the text of your abstract from a word processing document or a clipboard directly into the online abstract box.
All required fields must be complete, or the submission will be marked incomplete. Abstract submissions with an “incomplete” status cannot be processed.
Do not send multiple submissions of the same abstract. Duplicate abstracts will be rejected. Be sure to combine all the new information into one abstract.
Always keep an original copy of your submitted abstract.
Always proofread your abstract. Accepted abstracts will be published exactly as submitted.
ePosters must give a balanced view of therapeutic options. Brand names of pharmaceuticals and trade names of medical devices cannot be used in the title or body of the abstract. ACR reserves the right to replace proprietary names with generic names.
Institution names should not be included in the title or body of the abstract to keep the review process blind, fair, and objective. Alternative language that may be used is "at an institution", or "A multi-institution" study, etc. This does not apply to cooperative research group names such as RTOG, SWOG, ECOG, etc.

The Gold Merit Abstract Awards are presented to the highest scoring abstract in each subject category. Abstract scores are based on quality of the research and content, the accuracy of the research/content and interpretations, and relevance to the meeting.

The top scoring abstracts receive a Gold Merit Certificate Award as well as a monetary award. The recipient must complete a W-9 tax form. All accepted abstracts are considered. Recipients are highly encouraged to attend the ACR Annual Meeting to accept their Award.

The American College of Radiology (ACR) is accredited by the Accreditation Council on Continuing Medical Education (ACCME) to sponsor continuing medical education activities for physicians.

The ACR Financial Disclosure Policy
In compliance with ACCME requirements and guidelines, the ACR has developed a policy for review and disclosure of relevant financial relationships, and a method of mitigation if a relevant relationship does exist. The ACR maintains a tradition of scientific integrity and objectivity in its educational activities. In order to preserve this integrity and objectivity, all individuals participating as planners, presenters, authors, moderators and evaluators in an ACR educational activity or an activity jointly sponsored by the ACR must appropriately disclose any financial relationship, regardless of the amount, with ineligible companies within the prior 24 months.

For live presentations, all first and co-authors will be required to complete a disclosure form and attest that the statements in the form are accurate and the abstract complies with the U.S. Government’s Health Insurance Portability and Accountability Act of 1996 (HIPAA) privacy and data security standards. Authors must attest that the abstract will adhere to all ACCME Criteria and Standards for Integrity and Independence in Accredited CE.

ACR Mitigation Mechanism
The ACCME requires all accredited providers of CME to have a mechanism in place for identifying and mitigating potential financial interests prior to the educational offering. The ACCME considers a financial relationship relevant “when the educational content an individual can control is related to the business lines or products of the ineligible company” An ineligible company is defined as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACR requires that the first author of an abstract does NOT have a relevant financial relationship related to the scientific content of the abstract. If the first author has a relevant financial relationship related to the content, choose a co-author who does not have a relevant financial relationship related to the content to attend and answer attendee questions.

All first and co-authors agree to:

Attest that there are no third-party ownership or copyright restrictions
Give ACR permission to record, reproduce, and publish the abstract and findings in the meeting program, on the ACR website, in any additional proceedings related to the meeting, and in ACR online and print publications; and
Transfer copyright ownership of the accepted abstract to ACR. All authors of accepted abstracts are automatically issued a license to allow the reuse of their abstract at the time they transfer copyright ownership of their abstract to ACR. Authors need not contact the ACR to request permission to repurpose or build upon the work published in their abstract. This right only applies to abstract authors and does not preclude the need for permissions for non-authors to republish abstracts.

Abstract author(s) agrees to bear full responsibility for any claims, damages or losses that may occur because of any acts or omissions made during his or her presentation. ACR will have no liability for those acts or omissions. However, Abstract Author(s) will not have any such responsibility if ACR is proven to be solely negligent.

All accepted abstracts submitted to the ACR Annual Meeting are embargoed until the first day of the meeting and therefore, may not be announced, publicized or distributed before this date. The first author is responsible for conveying this information to all co-authors. For questions regarding the embargo policy, please contact annualmeeting@acr.org.

ACR requires that the content of abstracts and ePosters submitted to ACR meetings follow the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the U.S. Department of Health and Human Services regulations implementing this act. To comply with HIPAA regulations, patient confidentiality must be maintained in all education presentations, including ePoster sessions.

Members of the program committee and education staff will monitor presentations to identify ways to improve overall presentation quality and HIPAA compliance throughout the meeting.

Patient confidentiality must be protected. All materials (including slides, images, and posters) that are submitted to ACR must be deidentified according to HIPAA Safe Harbor or Expert Determination standards. All Names, dates of scans, birth dates, age, zip codes, medical record numbers and other HIPAA direct identifiers must be removed. More information on Expert Determination and Safe Harbor can be found on the Health and Human Services website.

Can I update my poster to reflect more recent work once the abstract was accepted?
Yes

Can I change the title of my abstract once the abstract was accepted?
No

Can I change or add authors once the abstract was accepted?
No, you must list all authors and coauthors before the submission site closes for review.

Does ACR offer grants for medical students?
No

Do I have to attend the meeting in person if my abstract was selected for a Gold Merit?
No, but it is highly recommended.

Can I get an extension on the abstract submission date?
The abstracts immediately go into the review process once the deadline is reached therefore, late submissions cannot be accepted.

Can I submit my abstract prior to obtaining official results?
The abstract submissions must be final and include results.

Can I use the ACR logo on my ePoster?
No, only your institution logo is permitted.

Once the abstract deadline closes, can I change the authors?
No, author changes and updates must be done prior to the deadline.

Can I submit an abstract to ACR if it was submitted at another meeting?
Yes, if it adheres to current ACR Abstract & ePoster guidelines.

Can I submit an abstract for educational review?
Abstracts focused on clinical radiology (i.e., more traditional abstracts seen at other national radiology meetings) will not be considered for this meeting. So, educational reviews may or may not be appropriate depending on the content they are reviewing. If the content is focused on learning techniques and tips, pearls and pitfalls, sort of content for residents, for instance, that would be acceptable content for the meeting, however a review of different types of hindfoot coalition would not be suitable content.

Loading component...

Call for Abstract Reviewers

We invite you to serve on the Abstract Review Committee. This is a one-year term in which you will be a part of ensuring abstract content is of high quality. The deadline to sign up is January 20, 2026.

Apply now

ACR Annual Meeting Call for Abstracts

Key Dates

General Information

Loading component...

Additional Information

Subject Categories

Author Requirements

Formatting Your Abstract

Gold Merit Awards

Disclosure of Relevant Financial Relationships Policy and Resolution

Originality and Copyright Policy

Hold Harmless Clause

Embargo Policy

Health Insurance Portability and Accountability Act of 1996 (HIPAA)

Frequent Asked Questions

Loading component...

Call for Abstract Reviewers

Loading component...

General Information

Additional Information

Subject Categories

Author Requirements

Formatting Your Abstract

Gold Merit Awards

Disclosure of Relevant Financial Relationships Policy and Resolution

Originality and Copyright Policy

Hold Harmless Clause

Embargo Policy

Health Insurance Portability and Accountability Act of 1996 (HIPAA)

Frequent Asked Questions

Call for Abstract Reviewers

Get the Latest ACR News